Stagezero Life Sciences Ltd (SZLSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 412 | 1,054 | 326 | 2,222 | 120 |
| Cost of Goods | 1,404 | 1,469 | N/A | N/A | 0 |
| Gross Profit | -993 | -415 | 326 | 2,222 | 120 |
| Operating Expenses | 4,570 | 4,749 | 6,281 | 9,175 | 5,450 |
| Operating Income | -5,158 | -4,695 | -5,956 | -6,953 | -5,330 |
| Interest Expense | 427 | 844 | 45 | 6 | 1,820 |
| Other Income | 2,637 | -372 | -89 | 8 | -1,980 |
| Pre-tax Income | -2,947 | -5,911 | -6,089 | -6,951 | -9,130 |
| Income Tax | N/A | N/A | -72 | N/A | 0 |
| Net Income Continuous | -2,947 | -5,911 | -6,017 | -6,951 | -6,604 |
| Net Income | $-2,947 | $-5,911 | $-6,017 | $-6,951 | $-9,130 |
| EPS Basic Total Ops | -0.24 | -0.72 | -0.88 | -1.28 | -2.00 |
| EPS Basic Continuous Ops | -0.24 | -0.72 | -0.90 | -1.17 | -1.57 |
| EPS Diluted Total Ops | -0.24 | -0.72 | -0.88 | -1.28 | -2.00 |
| EPS Diluted Continuous Ops | -0.24 | -0.72 | -0.90 | -1.17 | -1.57 |
| EPS Diluted Before Non-Recurring Items | -0.24 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-4,810 | $-4,353 | $-5,951 | $-6,936 | $-5,330 |